Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism
- 1 July 1990
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 163 (1) , 358-362
- https://doi.org/10.1016/0002-9378(90)90582-r
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Large buoyant LDL-like particles in hepatic lipase deficiency.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Der Effekt zweier niedrigdosierter Gestoden oder Desogestrel enthaltender Ovulationshemmer auf die Sexualhormone und den FettstoffwechselGeburtshilfe und Frauenheilkunde, 1988
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1981
- MENOPAUSAL OESTROGEN THERAPY AND PROTECTION FROM DEATH FROM ISCHAEMIC HEART DISEASEThe Lancet, 1981
- Epidemiology as a Guide to Clinical DecisionsNew England Journal of Medicine, 1980
- The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart diseaseEuropean Journal of Clinical Investigation, 1978
- The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by ImmunoassayJournal of Clinical Investigation, 1977
- THE TROMSØHEART-STUDYThe Lancet, 1977
- Mechanism of Hypertriglyceridaemia Associated with Contraceptive SteroidsHormone and Metabolic Research, 1973